Institute of Cancer Research, United Kingdom: all 113 studies

Page 2 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By SurgeryStatus unknownNCT00248521Phase 1
• Radiation Therapy in Treating Women With Localized Breast CancerCompletedNCT00107497Not applicable
• Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerStatus unknownNCT00079248Not applicable
• Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleStatus unknownNCT00077168Phase 2
• Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for CancerStatus unknownNCT00077090Phase 2
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell LymphomaCompletedNCT00053092Phase 2
• Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00052455Phase 3
• Positron Emission Tomography in Detecting Testicle CancerCompletedNCT00045045Not applicable
• Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
• Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerCompletedNCT00031850Not applicable
• Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedCompletedNCT00005586Phase 3
• Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent MelanomaCompletedNCT00002892Phase 3
• Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00002582Phase 3

← Institute of Cancer Research, United Kingdom overview and focus areas